Document is current
Any future updates will be listed below
-
Authors
Ringholm, Lene https://orcid.org/0000-0003-2971-8043
Do, Nicoline Callesen
Damm, Peter
Mathiesen, Elisabeth Reinhardt
- License Information
-
More Information
Article History
Received: 5 October 2021
Accepted: 21 December 2021
First Online: 11 February 2022
Declarations
:
: ERM have received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with preexisting diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation.
: This study was in accordance with the Helsinki declaration. In addition, the study was approved by The National Committee on Health Research Ethics (H-15019186 and H-15009413) and The Danish Data Protection Agency (2012-58-0004, RH-2015-289, I-Suite: 04305).
: All participants gave written informed consent before the data collection.
